Allogeneic stem cell transplantation for acute myeloid leukaemia 2005–22
Allogeneic stem cell transplantation is now a central component of treatment for AML. A steadily increasing number of patients are undergoing allogeneic stem cell transplantation with no observed decline in treatment outcomes.
Authors
- Geir E. Tjønnfjord (ORCID: https://orcid.org/0000-0002-7757-4091)
- Mats Remberger (ORCID: https://orcid.org/0000-0003-0520-4312)
- Pål Tore Bentsen
- Marianne Brenn Jerm
- Astrid Marta Olsnes
- Tobias Gedde‐Dahl (ORCID: https://orcid.org/0000-0002-3037-5378)
- Kari Busterud
Institutions
- Haukeland University Hospital (NO)
- Institutt for Eksperimentell Medisinsk Forskning (NO)
- Cancer Registry of Norway (NO)
- Smerteklinikken (NO)
Publication Details
- Journal
- Tidsskrift for Den norske legeforening
- Published
- 2025-10-07
- DOI
- https://doi.org/10.4045/tidsskr.25.0001
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00